Assoc. prof. Bago Pilátová Martina, DVM, PhD
Research/art/teacher profile
Date of last update: 22.10.2026
I. Basic information
| I.1 Surname |
Bago Pilátová |
|---|---|
| I.2 Given name |
Martina |
| I.3 Degrees |
Assoc. prof. , DVM, PhD |
| I.4 Year of birth |
1976 |
| I.5 Name of the workplace |
University of Veterinary Medicine and Pharmacy in Košice |
| I.6 Address of the workplace |
Komenského 73, 041 81 Košice, Slovak Republic |
| I.8 E-mail address | martina.pilatova@uvlf.sk |
| I.9 University staff register / partner university profile | https://www.portalvs.sk/regzam/detail/15102 |
| I.10 Study field in which the person works |
Pharmacy |
| I.11 ORCID iD | 0000-0002-9592-063X |
II. Higher education and further qualification growth
| Institution | Year | Study field and programme | |
|---|---|---|---|
| Second degree higher education | University of Veterinary Medicine in Košice | 2001 | food hygiene |
| Third degree higher education | Pavol Jozef Šafárik University, Faculty of Medicine | 2005 | pharmacology |
| Habilitation procedure | Pavol Jozef Šafárik University in Košice, Faculty of Medicine | 2012 | pharmacology |
III. Current and previous employment
| Occupation | Institution | Year |
|---|---|---|
associate professor | Pavol Jozef Šafárik University, Faculty of Medicine, Institute of Pharmacology | 2014 – to date |
researcher | Pavol Jozef Šafárik University, Faculty of Medicine, Institute of Pharmacology | 2005 – 2014 |
IV. Development of pedagogical, professional, language, digital and other skills
| Activity | Institution | Year |
|---|---|---|
Food toxicology and food safety | ILSI Europe, Wageningen, Netherlands | 2009 |
3rd European course of clinical cytometry | ESCCA (European Society for Clinical Cell Analysis - Amsterdam, Nedherlands), Antwerps, Belgium | 2007 |
1st European course of clinical cytometry | ESCCA (European Society for Clinical Cell Analysis - Amsterdam, Netherlands), Athens, Greece; Antwerps, Belgium | 2005 |
internship during university studies | Cancer Research Centre, Salamanca, Spain | 2003 |
internship during university studies | Institute of Virology, University of Veterinary Medicine, Wien, Austria | 1998 |
V. Overview of activities within the teaching career at the university
Academic year: 2026/2027
V.1. Overview of taught profile courses
No records yet.
V.2. Responsibility for the delivery, development and quality assurance of study programmes
No records yet.
V.3. Responsibility for the development and quality of habilitation and inauguration fields
No records yet.
V.4. Overview of supervised theses
| Bachelor | Master | Doctoral | |
|---|---|---|---|
| Currently supervised theses | 0 | 0 | 3 |
| Defended theses | 0 | 13 | 5 |
V.5. Overview of other taught courses
No records yet.
VI. Overview of research/artistic/other outputs
The last six completed calendar years: 2020–2025. The current year is excluded.
VI.1. Overview of research/artistic/other outputs and citations
| Total | Over the last six years | |
|---|---|---|
| VI.1.1 Number of research/artistic/other outputs | 178 | 44 |
| VI.1.2 Number of outputs registered in Web of Science or Scopus | 53 | 20 |
| VI.1.3 Number of citations corresponding to research/artistic/other outputs | 513 | 318 |
| VI.1.4 Number of citations registered in Web of Science or Scopus | 483 | 298 |
| VI.1.5 Number of invited lectures at international and national level | 0 | 0 |
VI.2. The most significant research/artistic/other outputs
| 1. | ADC: Martina Pilátová, Peter Kutschy, Roman Mezencev, Ladislav Mirossay, Andrej Miroššay, Ján Mojžiš, Kenji Monde, Mojmír Suchý, Marek Šarišský, Zuzana Čurillová: Cruciferous phytoalexins: antiproliferative effects in T-Jurkat leukemic cells. Leukemia Research. - Vol. 29, iss. 4 (2005), p. 415-421. 38 x |
|---|---|
| 2. | ADC: VAŠKOVÁ J, ČIŽMÁROVÁ B, BAGO PILÁTOVÁ M, KRON I, VAŠKO L: Effects of humic acids in vitro . In Vitro Cellular & Developmental Biology-Animal. 376-382, 2011. (IF=1,665) cit. 53 x |
| 3. | ADC: Bago Pilátová M., Varinská L., Perjési P., Šarišský M., Mirossay L., Solár P., Ostró A., Mojžiš J. „In vitro antiproliferative and antiangiogenic effects of synthetic analogues.“ Toxicol. In Vitro, 2010 (24/5), 1347-55. (IF= 2,457 -IF, Q1) cit. 51 x |
| 4. | ADD: Mezencev R, Mojžiš J, Pilátová M, Kutschy P: Antiproliferative and cancer chemopreventive activity of phytoalexins. Focus on indole phytoalexins from crucifers. Neoplasma, 239-245, 2003. (IF=1,721) cit. 41 x. |
| 5. | ADC: SELIGA R, BAGO PILÁTOVÁ M, ŠARIŠSKÝ M, VÍGLASKÝ V, WALKO M, MOJŽIŠ J: Novel naphthalimide polyamine derivatives as potential antitumor agents . Molecular Biology Reports, 4129-4137, 2013. (IF=2,107) cit. 24 x. |
VI.3. The most significant research/artistic/other outputs over the last six years
| 1. | ADC: Takáč P, Kello M, Bago Pilátová M, Kudličková Z, Vilková M, Slepčíková P, Petik P, Mojžiš J: New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. Chemico-Biological Interactions : a Journal of Molecular, Cellular and Biochemical Toxicology, 37-49, 2018 (IF= 3,723; Q1) cit. 22 x |
|---|---|
| 2. | ADC: Kello M, Drutovič D, Bago Pilátová M, Tischlerová V, Perjési P, Mojžiš J: Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis. Life Sciences, 32-38, 2016 (IF=3,647; Q1) cit. 23 x |
| 3. | ADC: Bogdanová A., Kello M., Macejová A., Nosalová N., Petik P., Takáč P., Martinková M., Mezeiová E., Mirossay L., Gál P., Bago Pilátová M.* „Jaspine B hydrochloride-induced apoptosis in HeLa cells is associated with disrupted shingolipid metabolism and ceramide overload.“ Anticancer Res 2021, 41, 2875-2883 (6), ADC (2020: 2.48 - IF, Q2 - JCR, Q2 - SJR) cit. 1x |
| 4. | ADC: Mojžišová G, Kello M, Pilátová M, Tomečková V, Vašková J, Vaško L, Bernatova S, Mirossay L, Mojžiš J: Antiproliferative effect of ß-escin - an in vitro study. Acta Biochimica Polonica, 79-87, 2016 (IF= 1,463; Q1). cit. 16 x. |
| 5. | ADC: Špaková Raschmanová, J.; Martinková, M.*; Gonda, J.; Bago Pilátová, M.; Kuchár, J.; Jáger, D. „Synthesis and in vitro biological evaluation of 3-amino-3-deoxydihydrosphingosines and their related analogues“ Tetrahedron 2020, 76, article number 130803, 1‒17. (0), ADC, (2019: 2.235 - IF= 2,235; Q2) cit. 2x |
VI.4. The most significant citations corresponding to research/artistic/other outputs
| 1. | Citovaný dokument: Pilátová M., Šarišský M., Kutschy P., Miroššay A., Mezencev R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., Mojžiš J.: Cruciferous phytoalexins: Antiproloferative effects in T-Jurkat leukemic cells. Leuk. Res. 29, 415-421, 2005. (IF=2,636; Q2) cit 38x; Ohlas: ADC: Banerjee, T., DuHadaway, J. B., Gaspari, P., Sutanto-Ward, E., Munn, D. H., Mellor, A. L., Malachowski, W. P., Prendergast, G. C.,(Muller, A. J.: A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase. Oncogene 27, 2851-2857, 2008 (IF=7.55; Q1) |
|---|---|
| 2. | Citovaný dokument: Pilátová M., Šarišský M., Kutschy P., Miroššay A., Mezencev R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., Mojžiš J.: Cruciferous phytoalexins: Antiproloferative effects in T-Jurkat leukemic cells. Leuk. Res. 29, 415-421, 2005. (IF=2,636; Q2) cit 38x; Ohlas: ADC: Solárová Z, Kello M, Varinská L, Budovská M, Solár P: AInhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluorophenylamino)- 4H-1,3-thiazine[6,5-b]indole in A2780cis cells. Biomedicine & Pharmacotherapy, 463-471, 2017 (IF=4,545; Q1) |
| 3. | Citovaný dokument: Pilátová M., Šarišský M., Kutschy P., Miroššay A., Mezencev R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., Mojžiš J.: Cruciferous phytoalexins: Antiproloferative effects in T-Jurkat leukemic cells. Leuk. Res. 29, 415-421, 2005. (IF=2,636; Q2) cit 36x; Ohlas: ADC: Banerjee, T., DuHadaway, J. B., Gaspari, P., Sutanto-Ward, E., Munn, D. H., Mellor, A. L., Malachowski, W. P., Prendergast, G. C.,Muller, A. J.: A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase. Oncogene 27, 2851-2857, 2008 (IF=7.55; Q1) |
| 4. | Citovaný dokument: Pilátová M, Stupáková V, Varinská L, Šarišský M, Mirossay L, Miroššay A, Gál P, Kraus V, Dianišková K, Mojžiš J: Effect of selected flavones on cancer and endothelial cells. General Physiology and Biophysics, 134-143, 2010 (IF=1,192; Q1) cit. 19 x; Ohlas: ADC: Calabriso N , Massaro M, Scoditti E, Pellegrino M, Ingrosso I, Giovinazzo G, Carluccio MA; et al.: Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases. Molecules, 1147, 2016 (IF=3,267; Q1) |
| 5. | Citovaný dokument: Pilátová M., Šarišský M., Kutschy P., Miroššay A., Mezencev R., Čurillová, Z., Suchý, M., Monde, K., Mirossay, L., Mojžiš J.: Cruciferous phytoalexins: Antiproloferative effects in T-Jurkat leukemic cells. Leuk. Res. 29, 415-421, 2005. (IF=2,636; Q2) cit 38x Ohlas: ADC: Yasuyuki I, Shingo Y, Yoshihiro S, Toshiyuki S: Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells. International Journal of Oncology, 816-824, 2012 (IF=3,899; Q1) |
VI.5. Participation in conducting or leading the most important projects over the last six years
| 1. | VEGA 11/0546/16: Antiproliferatívne účinky novonasyntetizovaných analógov jaspínu B a ich vplyv na nádorovú angiogenézu. Zodpovedný riešiteľ: Pilátová, Martina, MVDr. PhD. |
|---|---|
| 2. | VEGA 1/0304/10: Antiproliferatívny účinok indolových fytoalexínov a ich syntetických derivátov. Zodpovedný riešiteľ: Pilátová, Martina, MVDr. PhD. |
| 3. | VEGA 1/0753/17; Vplyv prírodných látok na nádorové mikroprostredie. Roky realizácie: 2017-2020, Pozícia: zástupca |
| 4. | VEGA 1/0322/14: Indolové fytoalexíny - mechanizmus antiproliferatívneho účinku. Roky realizácie: 2014-2016. Zodpovedný riešiteľ: prof. MVDr. J. Mojžiš, CSc.; zástupca ved. projektu: Pilátová, Martina, doc. MVDr. PhD. |
| 5. | VEGA 1/0617/22: SLAMF receptory u chronickej lymfocytovej leukémie - potenciálne ciele protinádorovej liečby. Zodpovedný riešiteľ: PharmDr. M. Šarišský, PhD.; zástupca ved. projektu: Bago Pilátová, Martina, doc. MVDr. PhD. |
VII. Overview of organizational experience related to higher education and research/artistic/other activities
No records yet.
VIII. Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study
| Institution | Address | Mobility scheme, employment contract, other | Year |
|---|---|---|---|
European Society for Clinical Cell Analysis (ESCCA) | Amsterdam, Netherlands | 3rd European course in clinical cytometry | 2007 – 2007 |
European Society for Clinical Cell Analysis (ESCCA) | Amsterdam, Netherlands | 1st European course in clinical cytometry | 2005 – 2005 |
Cancer Research Centre | Salamanca, Spain | Erasmus Fellowship | 2003 – 2003 |